Next-generation Sequencing Market: Growing at a CAGR of 22.2%
Next-Generation Sequencing (NGS) Market Size, Share and Industry Analysis By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Regional Forecast 2026
Next-generation sequencing (NGS) is a type of DNA sequencing that is faster and more affordable than traditional methods. NGS is used to sequence the genomes of individuals, organisms, and even entire ecosystems.
Global Next-Generation Sequencing Market size was valued at US$ 6,335.2 Million in 2018 and is Projected to Reach US$ 31,411.3 Million by 2026, exhibiting a CAGR of 22.2% By 2026 period.
Get More Insights: https://www.fortunebusinessinsights.com/industry-reports/next-generation-sequencing-ngs-market-101000
This growth is being driven by the increasing demand for NGS in a variety of applications, including:
- Personalized medicine: NGS is used to identify genetic mutations that are associated with diseases. This information can be used to develop personalized treatments for patients.
- Clinical diagnostics: NGS is used to diagnose diseases, such as cancer and rare genetic disorders.
- Research: NGS is used to study the genomes of organisms, such as bacteria, viruses, and plants. This information can be used to develop new drugs and treatments.
- Forensics: NGS is used to identify individuals and to solve crimes.
Segmentation
The NGS market is segmented by product, application, and region.
The product segment is further segmented into sequencing instruments, reagents, and consumables. Sequencing instruments are the largest segment, and they include machines that are used to sequence DNA. Reagents are the second largest segment, and they include chemicals that are used in the sequencing process. Consumables are the smallest segment, and they include items such as pipette tips and gloves.
The application segment is further segmented into clinical diagnostics, research, and forensics. Clinical diagnostics is the largest segment, and it includes applications such as cancer diagnostics and rare disease diagnostics. Research is the second largest segment, and it includes applications such as genome sequencing and gene expression analysis. Forensics is the smallest segment, and it includes applications such as DNA profiling and disaster victim identification.
The region segment is further segmented into North America, Europe, Asia-Pacific, and Latin America. North America is the largest market for NGS, followed by Europe and Asia-Pacific. Latin America is the smallest market, but it is growing at the fastest pace.
Key Players
The key players in the NGS market include Illumina, Thermo Fisher Scientific, 10x Genomics, Pacific Biosciences, and Roche. These companies are investing in research and development to develop new and innovative NGS technologies.
Trends
The NGS market is expected to continue to grow in the coming years, driven by the following trends:
- Increasing demand for personalized medicine: The increasing demand for personalized medicine is driving the growth of the NGS market. NGS can be used to identify genetic mutations that are associated with diseases. This information can be used to develop personalized treatments for patients.
- Falling prices of NGS: The prices of NGS instruments and reagents are falling, which is making NGS more affordable for researchers and clinicians.
- Development of new NGS technologies: There are a number of new NGS technologies in development, such as single-molecule real-time sequencing and nanopore sequencing. These technologies are more accurate and faster than traditional NGS technologies.
Conclusion
The NGS market is a growing market, and it is expected to continue to grow in the coming years. The market is being driven by the increasing demand for personalized medicine, the falling prices of NGS, and the development of new NGS technologies.
